← Leaderboards
Jesus Tejero Bravo
University Of Pittsburgh At Pittsburgh
$3,879,160
Attributed
$7,049,587
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,049,587 · 3
By mechanism
R01$4,889,798 · 1
R42$1,733,830 · 1
R21$425,959 · 1
Top collaborators
- Mark Thomas Gladwin6 shared
- Jason J Rose3 shared
- George Douglas Leikauf2 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Jason J Rose$2,931,344
- Matthew Ryan Dent$900,832
- David Alan Greenberg$16,853,059
- Shaun Carlson$2,257,881
- Paola Corti$900,900
Others in their field
Top investigators on “Affinity”
- Dennis R. Burton · Scripps Research Institute$64,397,776
- James E Crowe · Vanderbilt University Medical Center$53,471,415
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$45,445,140
- Timothy A Springer · Boston Children'S Hospital$41,593,445
- Misty Ward Stevens · Intervexion Therapeutics, Llc$38,187,594
- Rafi Ahmed · Emory University$36,776,987
Research focus
AffinityExhibitsOxygenCarbon Monoxide PoisoningMitochondriaHemoglobinIn VitroIn VivoNeuroglobinPoisoningBindingCarbon MonoxideFire - DisastersCessation Of LifeHemeHuman EngineeringAntidotesFundingCytochrome C OxidaseExposure ToHeartBrainExcisionErythrocytes
Grant awards (12)
Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin$676,342
R01 · FY2025 · HL
Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin$660,807
R01 · FY2024 · HL
Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin$703,592
R01 · FY2023 · HL
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning$734,942
R42 · FY2022 · ES · contact PI
Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin$708,733
R01 · FY2022 · HL · contact PI
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning$748,895
R42 · FY2021 · ES · contact PI
Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin$708,733
R01 · FY2021 · HL
Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin$708,733
R01 · FY2020 · HL
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning$249,993
R42 · FY2020 · ES · contact PI
Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin$722,858
R01 · FY2019 · HL
Countermeasure Therapeutics for Acute Lung Injury$194,584
R21 · FY2017 · ES
Countermeasure Therapeutics for Acute Lung Injury$231,375
R21 · FY2016 · ES